GRADY LAB -- Grady Lab

Welcome to the Grady Lab

The Grady lab research is focused on the role of epigenetic alterations as risk markers and biomarkers for esophageal and colon cancer, respectively, and of the role of genetic and epigenetic alterations in carcinogenesis.

Specific studies include:

  • Assessing the role of the genetic and epigenetic alterations in the initiation and progression of colorectal and esophageal cancer.

  • Determining novel treatment approaches to colorectal cancer.

  • Identifying molecular factors that influence the risk for colorectal cancer. Germane to this RFA, Dr. Grady will bring his expertise in the colorectal cancer biology and clinical medicine to the collaborative team efforts to advance the use of GCC as a novel target for imaging and therapy.